Raiffeisen Bank International AG
BankPosition in DGX — Quest Diagnostics Inc
CIK 2044885
VIENNA, C4
Position in DGX
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$50,656
+$32,822 QoQ
Shares Held
239
+162.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#903
of 1,090 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DGX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Raiffeisen Bank International AG holds $157,238,037 across 12 Diagnostics & Research names. DGX ranks #8 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
138,757 | $69,567,209 | |
| 2 | DHR |
Danaher Corp /De/
|
162,772 | $31,004,810 | |
| 3 | MTD |
Mettler Toledo International Inc/
|
17,287 | $22,084,315 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
41,815 | $22,013,088 | |
| 5 | A |
Agilent Technologies, Inc.
|
73,572 | $9,772,568 | |
| 6 | CRL |
Charles River Laboratories International, Inc.
|
6,000 | $1,360,740 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
6,500 | $1,255,930 | |
| 8 | DGX |
Quest Diagnostics Inc
This page
|
239 | $50,656 |
All Filings in DGX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $50,656 | 239 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $17,834 | 91 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $15,791 | 91 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $17,342 | 91 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $463,984 | 2,583 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $606,751 | 3,586 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $545,811 | 3,618 | Shares | Defined | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||